Informacin importante Requiere presentar receta mdica
New York, USA, June 26, 2024 (GLOBE NEWSWIRE) -- GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca The GLP-1 agonists market is poised for exponential growth fueled by advancements in drug delivery systems and expanding indications
Using an animal model over a 21 day period, scientists observed several notable changes: A decline in beneficial gut bacteria that break down dietary fibre Lower levels of short chain fatty acids, which support the gut lining and help control inflammation Increased levels of inflammatory markers in the blood Greater liver weight, a possible sign of low grade inflammation A smaller cecum -- the part of the intestine where gut bacteria break down fibre and produce protective compounds Reduced levels of a brain derived protein associated with cognitive impairment The study does not prove that SNAC is harmful
And should these new weight loss medications play a role
Cancer Res 1996